Clinical Trials Directory

Trials / Unknown

UnknownNCT05534217

The Debridement To Treat The Traumatic Corneal Abrasion

A Prospective, Randomized, Double-blind, Controlled Clinical Study of Corneal Debridement to Treat the Traumatic Corneal Abrasion

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
156 (estimated)
Sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Patients who signed informed consent to participate in the study will receive corneal epithelial deplasia. The patient was instructed to follow up closely in the following year, and the recurrence of the patient was collected through wechat follow-up.

Detailed description

Traumatic corneal abrasion (TCA) refers to the injury or defect of the corneal epithelium caused by a foreign object (such as a nail, a tree branch, etc.), which is characterized by severe eye pain accompanied by red eyes, blepharospasm, photophobia, tearing, and a distinct foreign body sensation. TCA is one of the common eye injuries and ophthalmic emergencies, accounting for about 5%-10% in ophthalmic emergencies. Methods: The investigators conducted a clinical trial in adult patients with corneal trauma at the Zhongshan Ophthalmology Center of Sun Yat-sen University. Patients who signed informed consent to participate in the study were provided with corneal epithelial debridement. Patients were instructed to follow closely for the following year, and a pain log of the patient was collected at the last ophthalmology clinic visit.

Conditions

Interventions

TypeNameDescription
BIOLOGICALcorneal debridement of corneal abrasionSurgical debridement for traumatic corneal epithelial abrasions

Timeline

Start date
2022-12-31
Primary completion
2023-09-01
Completion
2024-01-01
First posted
2022-09-09
Last updated
2022-09-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05534217. Inclusion in this directory is not an endorsement.